New Concepts in ACS: Beyond 2000 (XXIII)

Monday, October 23
7:00 – 8:45 AM

Vancouver, BC

Chair: Paul W. Armstrong

Co-Chair: Shaun Goodman

2017 Sponsors
of New Concepts in ACS: Beyond 2000 (XXIII)

This accredited symposium was co-developed with the Canadian Cardiovascular Society, Mazankowski Alberta Heart Institute/University of Alberta, Canadian VIGOUR Centre, AstraZeneca Canada Inc., Bayer Inc., Merck Canada Inc. and Novartis Pharmaceuticals Canada Inc. and was planned to achieve scientific integrity, objectivity and balance.

Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™.

Live educational activities, occurring in Canada, recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC credits.



New Concepts in ACS: Beyond 2000 (XXIII)


Monday, October 23, 2017


Learning Objectives

  • Formulate a revised plan for lipid lowering in patients convalescing from acute coronary syndromes.
  • Apply reasoned risk-benefit considerations in choosing DAPT and oral anti-thrombotic therapy post-MI.
  • Integrating new data on the initial evaluation of the patient presenting with acute undifferentiated chest pain.
  • Incorporate new knowledge in acute coronary syndromes into current patient care.